Neuland Laboratories Ltd Quarterly Results

Gross Sales

328.36

398.03

310.84

439.6

385.01

Excise Duty

0

0

0

0

0

Net Sales

328.36

398.03

310.84

439.6

385.01

Other Operating Income

0

0

0

0

0

Other Income

7.46

59.68

4.33

25.43

5.36

Total Income

335.82

457.72

315.18

465.03

390.37

Total Expenditure

277.29

311.43

248.62

316.24

278.09

PBIDT

58.54

146.28

66.56

148.79

112.27

Interest

2.35

2.22

1.06

2.67

3.61

PBDT

56.19

144.07

65.5

146.12

108.66

Depreciation

16.89

16.3

16.07

16.28

16.46

Minority Interest Before NP

0

0

0

0

0

Tax

6.02

24.95

12.21

30.58

21.99

Deferred Tax

5.47

1.23

4.37

1.39

2.65

Reported Profit After Tax

27.81

101.59

32.84

97.87

67.56

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

27.81

101.59

32.84

97.87

67.56

Extra-ordinary Items

0

44.35

0

15.55

0

Adjusted Profit After Extra-ordinary item

27.81

57.24

32.84

82.32

67.56

EPS (Unit Curr.)

21.67

79.18

25.6

76.28

52.66

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

12.9

12.9

12.9

12.9

12.9

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

17.82

36.75

21.41

33.84

29.16

PBDTM(%)

17.11

36.19

21.07

33.23

28.22

PATM(%)

8.46

25.52

10.56

22.26

17.54